John McKenna

John McKenna is the Chief Financial Officer (CFO) of Novartis USA, a position he has held since February 2022. He is responsible for overseeing the financial operations of Novartis' US Branded Medicines Business, which generates approximately $16 billion in net sales. McKenna's extensive career in finance spans several prominent roles within the pharmaceutical industry.

Professional Background

• CFO, Novartis Pharmaceuticals Corp. (September 2017 - February 2022): Prior to his current role, he served as CFO for Novartis Pharmaceuticals, focusing on high-performance strategies and new product launches.
• CFO, North America, AstraZeneca (August 2014 - September 2017): Here, he managed significant financial operations and navigated the challenges of a major patent cliff.
• CFO, North America, Alcon (July 2011 - August 2014): McKenna played a key role in integrating CIBA Vision into Alcon, enhancing its market position.
• Various CFO roles within Novartis: His tenure at Novartis began in the late 1990s and included multiple leadership positions across different divisions, including CIBA Vision and Novartis Consumer Health.

Education and Qualifications

John McKenna holds several degrees and certifications:

• Bachelor of Commerce (B.Comm) from McMaster University
• Master of Arts (M.A.) in Organizational Leadership from Gonzaga University
• CPA (Canada) and CMA (USA) designations

He has also completed advanced programs at Harvard Business School and Temple University's Fox School of Business.

Personal Information

McKenna is a dual citizen of the United States and Canada. He is married with two children and is known for his leadership style that emphasizes team building and strategic financial management in complex business environments.123